Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joerg Herrmann MD
Joerg Herrmann MD Associate Editor
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · April 26, 2018

Dual Is Likely Better Than Triple Antithrombotic Therapy After PCI in Patients With Atrial Fibrillation

European Heart Journal

 

 Save  Recommend
 Share

Additional Info

European Heart Journal
Safety and Efficacy of Dual vs Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Eur Heart J 2018 Apr 13;[EPub Ahead of Print], HB Golwala, CP Cannon, PG Steg, G Doros, A Qamar, SG Ellis, J Oldgren, JM Ten Berg, T Kimura, SH Hohnloser, GYH Lip, DL Bhatt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated